BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3739Biotechnology
$7.88 −$0.81 (-9.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.88 0.00%
Open$8.52
Prev close$8.69
Day range$7.84 – $9.13
Volume419.1K
Market cap$203.65M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

FTH at a glance

FTH is priced at $7.88 right now, down 9.32% on the session. That puts its market value at $203.65M, 3739th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($7.45 to $42.14), 81.3% under the high. Holders are behind 9.6% over twelve months, and down 77.3% across the last three months.

On the chart it has slipped under both the 50-day ($22.10) and 200-day ($25.42) moving averages; RSI is 23, which some call oversold, and the last 30 sessions moved at roughly 193% annualized volatility.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, and a net loss of $20.40M.

10 analysts follow the stock and the average call is "buy". The mean target, $57.78, sits 633.2% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$7.73 / $10.50
Average price today$8.26
Volume419.1KAvg (90d) 440.6K
Turnover$3.46M
Turnover rate2.48%of shares outstanding
Volume ratio0.62vs. recent average pace
Day amplitude14.87%
Market cap$203.65M
Float market cap$132.95M
Shares outstanding16.87M
EPS (TTM)-$16.72
P/B1.26
Book value / share$6.23
Net profit (TTM)-$432.11M
Net assets$161.09M
30-day volatility192.7%annualized
Avg daily range (ATR)28.15%of price, 14 days
Max drawdown (1y)-80.3%-80.3% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

F
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

10 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 23.5 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability2.7
Momentum17.8
Financial health58.5
Analyst view99.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$57.78+633.2% vs. current price
Consensus ratingBuy10 analysts covering
Morningstar fair value$33.15Price is below fair value

Wall Street’s average 12-month target is $57.78, 633.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $33.15, so shares trade 76.2% below that estimate. On earnings multiple, it sits in the 92nd percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-9.3%
1 week
-21.4%
1 month
-60.8%
3 months
-77.3%
6 months
-55.7%
Year to date
-26.1%
1 year
-9.6%
Day range
$7.84$9.13
52-week range
$7.45$42.14

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-46.9%Bearish
Price vs 50-day average-64.3%Bearish
Price vs 200-day average-69.0%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)23.0Neutral
MACD (12,26,9)-3.96Bearish
Bollinger band position15%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How FTH ranks on BeStock

Market value#3721 of 3734
Closeness to 52-week high#3648 of 3724
Dollar volume today#2778 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

FTH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on FTH.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on FTH

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

FTH stock: common questions

How is Faeth Therapeutics stock doing today?

$7.88 is the latest print for FTH, a move of -9.32% against yesterday's close of $8.69. Today's low and high so far: $7.84 and $9.13.

How large is Faeth Therapeutics by market value?

Equity value comes to $203.65M at the current price. By that measure it is number 3739 of the 3753 names in our coverage.

Is FTH near its 52-week high or low?

The year's floor is $7.45 and the ceiling $42.14. Shares are 81.3% away from that ceiling.

Does Faeth Therapeutics pay a dividend?

Our data shows no dividend paid by Faeth Therapeutics over the trailing twelve months.

Is FTH rated a buy by Wall Street?

Of 10 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $57.78, with the most cautious at $40.00 and the most optimistic at $69.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on FTH.

Sign in to join the discussion.

Scroll to Top